1. Home
  2. VKTX vs EVTC Comparison

VKTX vs EVTC Comparison

Compare VKTX & EVTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • EVTC
  • Stock Information
  • Founded
  • VKTX 2012
  • EVTC 1988
  • Country
  • VKTX United States
  • EVTC United States
  • Employees
  • VKTX N/A
  • EVTC N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • EVTC EDP Services
  • Sector
  • VKTX Health Care
  • EVTC Technology
  • Exchange
  • VKTX Nasdaq
  • EVTC Nasdaq
  • Market Cap
  • VKTX 2.8B
  • EVTC 2.3B
  • IPO Year
  • VKTX 2015
  • EVTC 2013
  • Fundamental
  • Price
  • VKTX $28.14
  • EVTC $37.51
  • Analyst Decision
  • VKTX Buy
  • EVTC Buy
  • Analyst Count
  • VKTX 12
  • EVTC 4
  • Target Price
  • VKTX $84.00
  • EVTC $40.00
  • AVG Volume (30 Days)
  • VKTX 3.9M
  • EVTC 299.8K
  • Earning Date
  • VKTX 07-23-2025
  • EVTC 07-30-2025
  • Dividend Yield
  • VKTX N/A
  • EVTC 0.53%
  • EPS Growth
  • VKTX N/A
  • EVTC 101.39
  • EPS
  • VKTX N/A
  • EVTC 2.00
  • Revenue
  • VKTX N/A
  • EVTC $868,960,000.00
  • Revenue This Year
  • VKTX N/A
  • EVTC $7.88
  • Revenue Next Year
  • VKTX N/A
  • EVTC $4.98
  • P/E Ratio
  • VKTX N/A
  • EVTC $18.80
  • Revenue Growth
  • VKTX N/A
  • EVTC 17.39
  • 52 Week Low
  • VKTX $18.92
  • EVTC $28.76
  • 52 Week High
  • VKTX $81.73
  • EVTC $38.56
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 55.39
  • EVTC 60.61
  • Support Level
  • VKTX $25.80
  • EVTC $35.73
  • Resistance Level
  • VKTX $28.80
  • EVTC $36.83
  • Average True Range (ATR)
  • VKTX 1.65
  • EVTC 0.70
  • MACD
  • VKTX 0.11
  • EVTC 0.08
  • Stochastic Oscillator
  • VKTX 86.93
  • EVTC 93.49

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

Share on Social Networks: